2/13
07:46 pm
ocs
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares [Yahoo! Finance]
Low
Report
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares [Yahoo! Finance]
2/13
07:39 pm
ocs
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares
Low
Report
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares
2/6
06:32 am
ocs
We're Hopeful That Oculis Holding (NASDAQ:OCS) Will Use Its Cash Wisely [Yahoo! Finance]
Low
Report
We're Hopeful That Oculis Holding (NASDAQ:OCS) Will Use Its Cash Wisely [Yahoo! Finance]
1/7
08:20 am
ocs
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
Low
Report
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
1/6
12:46 pm
ocs
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
1/6
03:53 am
ocs
Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy
Low
Report
Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy